Diaceutics PLC
DIUXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $13 | $17 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $15 | $10 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $1 | $1 |
| Total Curr. Assets | $24 | $30 | $27 | $28 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15 | $15 | $15 | $15 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $3 | $2 | $2 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $20 | $19 | $18 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $44 | $49 | $45 | $46 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $4 | $6 | $5 | $3 |
| Total Curr. Liab. | $6 | $8 | $6 | $4 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $7 | $9 | $7 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $39 | $41 | $2 | $4 |
| AOCI | -$1 | $0 | -$0 | $0 |
| Other Equity | -$0 | -$1 | $37 | $37 |
| Total Equity | $37 | $40 | $39 | $41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $44 | $49 | $45 | $46 |
| Net Debt | -$9 | -$12 | -$16 | -$15 |